These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3337542)

  • 21. An immunofluorescence study of light chain in pemphigus.
    Igarashi R; Morohashi M; Inomata N; Sato Y
    Acta Derm Venereol; 1980; 60(2):123-28. PubMed ID: 6155017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pemphigus foliaceus in a child. A two years follow-up under steroid. An immunosuppression therapy (author's transl)].
    Larrègue M; Bressieux JM; Bureau B; Gallet P; Rat JP; Pinalie A; de Giacomoni P
    Ann Dermatol Venereol; 1980 May; 107(5):389-95. PubMed ID: 7224523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen.
    Eyre RW; Stanley JR
    J Clin Invest; 1988 Mar; 81(3):807-12. PubMed ID: 3343340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pemphigus foliaceus.
    van Vloten WA
    Dermatologica; 1972; 144(6):356. PubMed ID: 4567872
    [No Abstract]   [Full Text] [Related]  

  • 25. Isolation and purification of a pemphigus vulgaris antigen from human epidermis.
    Peterson LL; Wuepper KD
    J Clin Invest; 1984 Apr; 73(4):1113-20. PubMed ID: 6707207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3).
    Kubo A; Amagai M; Hashimoto T; Doi T; Higashiyama M; Hashimoto K; Yoshikawa K
    Br J Dermatol; 1997 Jul; 137(1):109-13. PubMed ID: 9274636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tunisian pemphigus foliaceus with antidesmoglein 3 antibody].
    Masmoudi A; Baricault S; Chikrouhou H; Zahaf A; Turki H; Abida O; Ben Ayed M; Masmoudi H; Gilbert D; Tron F; Joly P
    Ann Dermatol Venereol; 2008 Jan; 135(1):69-70. PubMed ID: 18342079
    [No Abstract]   [Full Text] [Related]  

  • 28. Pemphigus foliaceus presenting as eruptive seborrheic keratosis and responding to oral gold treatment.
    Bagheri MM; Alagheband M; Memar OM; Eiler DB
    J Drugs Dermatol; 2002 Dec; 1(3):333-4. PubMed ID: 12851996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of pemphigus foliaceus in a patient with psoriasis: a simple coincidence?
    Tomasini D; Cerri A; Cozzani E; Berti E
    Eur J Dermatol; 1998; 8(1):56-9. PubMed ID: 9649683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generalized erythrodermic pemphigus foliaceus in a child and its successful response to rituximab treatment.
    Connelly EA; Aber C; Kleiner G; Nousari C; Charles C; Schachner LA
    Pediatr Dermatol; 2007; 24(2):172-6. PubMed ID: 17461818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pemphigus foliaceus treated with etanercept.
    Gubinelli E; Bergamo F; Didona B; Annessi G; Atzori F; Raskovic D
    J Am Acad Dermatol; 2006 Dec; 55(6):1107-8. PubMed ID: 17110226
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pemphigus, pregnancy and cortisone therapy].
    Stevanović DV
    Hautarzt; 1966 Mar; 17(3):118-21. PubMed ID: 5987519
    [No Abstract]   [Full Text] [Related]  

  • 33. Neonatal pemphigus vulgaris.
    Gushi M; Yamamoto Y; Mine Y; Awazawa R; Nonaka K; Taira K; Asato Y; Hagiwara K; Uezato H
    J Dermatol; 2008 Aug; 35(8):529-35. PubMed ID: 18789074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.
    Allen KJ; Wolverton SE
    J Drugs Dermatol; 2007 Sep; 6(9):883-9. PubMed ID: 17941359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-desmoglein 1 antibodies in healthy related and unrelated subjects and patients with pemphigus foliaceus in endemic and non-endemic areas from Tunisia.
    Abida O; Kallel-Sellami M; Joly P; Ben Ayed M; Zitouni M; Masmoudi A; Mokni M; Fezzaa B; Ben Osman A; Kammoun MR; Gilbert D; Turki H; Tron F; Masmoudi H; Makni S;
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1073-8. PubMed ID: 19453789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus.
    Arin MJ; Engert A; Krieg T; Hunzelmann N
    Br J Dermatol; 2005 Sep; 153(3):620-5. PubMed ID: 16120153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients.
    Frusic-Zlotkin M; Pergamentz R; Michel B; David M; Mimouni D; Brégégère F; Milner Y
    Ann N Y Acad Sci; 2005 Jun; 1050():371-9. PubMed ID: 16014554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of methotrexate to treat pemphigus foliaceus.
    Rivitti EA; Camargo ME; Castro RM; Sampaio SA
    Int J Dermatol; 1973; 12(2):119-22. PubMed ID: 4697341
    [No Abstract]   [Full Text] [Related]  

  • 39. Congenital pemphigus. Report of three cases.
    Bajpai PC; Gupta SP; Mathur M
    Indian J Pediatr; 1968 Dec; 35(251):556-60. PubMed ID: 5753726
    [No Abstract]   [Full Text] [Related]  

  • 40. Neonatal pemphigus.
    Moncada B; Sandoval-Cruz JM; Baranda L; Garcia-Reyes J
    Int J Dermatol; 1989 Mar; 28(2):123-4. PubMed ID: 2737807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.